Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Seeing increasing demand for biologic drugs in China, Thermo Fisher Scientific has formed a joint venture with Innoforce Pharmaceuticals, a biologic-drug services firm in Hangzhou, China, aimed at establishing a biologic-and-sterile-drug development and manufacturing facility in Hangzhou by 2022. Earlier this year, Thermo Fisher opened a bioprocess development services center at its Saint Louis biologics complex. Thermo Fisher has said it plans to spend more than $475 million on biopharmaceutical capabilities and capacity this year.
This article has been sent to the following recipient: